TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) Executive Chairman Kirill Klip discusses latest developments at the Los Azules project in Argentina with Proactive's Stephen Gunnion, highlighting an improved copper recovery rate, significant project scale, and future potential.

Klip stated that TNR Gold is evolving into a green energy metals royalty and gold company through its portfolio, which includes a 0.4% net smelter returns (NSR) royalty on the giant Los Azules copper, gold, and silver project.

Recent results from McEwen Copper Inc, a subsidiary of McEwen Mining, indicate a 3.2% increase in copper recovery at Los Azules, translating into an additional 172,000 tonnes of copper over the mine's 27-year lifespan. Klip also detailed the project's scale, with a preliminary economic assessment showing 27% increase in total copper, amounting to 11 billion pounds in the indicated category and 27 billion pounds in inferred category. This could equate to 68 million ounces of gold project equivalent.

The Los Azules project, being among the world's ten largest copper projects, promises a substantial economic impact on Argentina. Klip suggested that Argentina offers a favorable political and economic environment for investments, potentially enhancing TNR Gold's valuation.

Additionally, Klip mentioned ongoing drilling campaigns and a forthcoming feasibility study expected in the first quarter of 2025.

The interview also touched on royalty M&A deals and potential valuations, with gold reaching all-time highs and copper expected to follow due to electrification and the green economy transition.

#TNRGold #LosAzules #CopperMining #Argentina #GreenEnergy #GoldMining #MetalsRoyalty #EconomicImpact #DrillingUpdate #MiningInvestment #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Aura Minerals Inc chief financial officer Kleber Cardoso joins Proactive's Angela Harmantas at PDAC 2024 with more on the Latin American-focused gold and copper producer and the significant growth it's currently experiencing.

In 2023, Aura made crucial progress towards its goal of increasing production by nearly 90% by 2025, with the introduction of three new mines. The company successfully transitioned from three to four operations, notably by bringing the Almas project in Brazil to completion. This new mine, constructed on time and within budget at $75 million over 16 months, reached commercial production five months later. In 2023, Aura produced 136,000 ounces of gold equivalents, with expectations to boost production by 10-20% in 2024 due to the new mine's full operation.

Aura aims to nearly double its output to 450,000 ounces of gold equivalent by 2025, with significant contributions from the Borborema project in Brazil, expected to produce 85,000 ounces annually. The project, already 20% complete and fully funded, benefits from fixed pricing for over half of its capital expenditure, mitigating inflation risks and aiming for an early 2025 production start.

Beyond Borborema, Aura plans to continue its growth by advancing other projects in Brazil, including the Matupá project, with all necessary permits and feasibility studies completed. This project, along with three early-stage ventures, is part of Aura's strategy to maintain its growth trajectory, aiming for continued expansion into 2025 and beyond.

#AuraMinerals #GoldProduction #CopperMining #LatinAmericaMining #MiningExpansion #BrazilMiningProjects #VorpalRhema #AlmasProject #MiningIndustry #SustainableMining #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

ImmuPharma PLC (AIM:IMM) chief executive Tim McCarthy provides an extensive update during an interview with Proactive's Stephen Gunnion, focusing on the financial, business, and portfolio developments of the company.

McCarthy clarified that the company is in a strong financial position, dismissing rumours of needing a highly dilutive fundraising. He emphasized that ImmuPharma has sufficient funding for its needs, supported by a business model reliant on developing drugs to a stage attractive to larger pharmaceutical companies for further development and market introduction. This strategy, according to McCarthy, is expected to generate non-dilutive upfront payments and royalties from licensing agreements, particularly for their P140 platform focused on autoimmune diseases like lupus and CIDP (Chronic Idiopathic Demyelinating Polyneuropathy).

McCarthy detailed progress on the lupus program, including changes to their clinical study approach and discussions with the FDA, highlighting the uniqueness of their molecule's mechanism of action. This uniqueness, McCarthy pointed out, has garnered interest from big pharma, distinguishing their lupus treatment from others that failed due to efficacy or side effects issues. Moreover, he announced advancements in the CIDP program and the company's intention to achieve orphan drug designation for it, promising significant market potential despite its smaller patient population compared to lupus.

The CEO also touched on an early-stage anti-infective program, underscoring the evolution of ImmuPharma's drug portfolio over the last two and a half years under his leadership. This transformation involved corporate restructuring, significant cost reductions, and strategic focus on developing a diversified drug portfolio.

McCarthy concluded by affirming the company's position as substantially undervalued based on its developmental and financial assets, particularly highlighting a major interest in the oncology company Incanthera, which recently secured a substantial commercial deal with AS Watson.

#ImmuPharma #TimMcCarthy #Pharmaceuticals #LupusResearch #CIDP #DrugDevelopment #PharmaInvestments #Biotech #AutoimmuneDiseases #HealthcareInnovation #proactiveinvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Kootenay Silver Inc (TSX-V:KTN) CEO Jim McDonald shares an update on the company's projects with Proactive's Angela Harmantas at PDAC 2024 conferenc.

McDonald told Proactive the company is experiencing positive momentum from the gold and silver markets, contributing to a buoyant atmosphere among stakeholders. He highlighted the progress of the company's flagship project, the Columba project in Mexico, known for its silver deposits. This project, described as a newly discovered vein district, remains largely unexposed to erosion, preserving its original deposits. Over three years, Kootenay Silver has drilled 30,000 metres across 147 holes, with plans to drill an additional 5,000 metres in approximately 24 holes, focusing on the D vein which has shown significant silver intercepts.

The company aims to establish a maiden resource for Columba by the end of 2024, contingent on market conditions and fundraising efforts, estimating a requirement of an additional 20,000 metres of drilling.

Additionally, McDonald discussed the La Cigarra project, also in Mexico, which has recently updated its mineral resource estimate. The revision has increased the measured and indicated grade from 85-86 grammes of silver per tonne to 102 grammes per tonne, without loss of material. This update enhances the project's economic viability, especially with silver prices approaching or exceeding $30, contributing to Kootenay Silver's potential for growth in a bullish silver market.

#KootenaySilver #MiningUpdate #SilverMining #ColumbaProject #LaCigarra #MineralResources #SilverMarket #DrillingResults #MaidenResource #PDAC2024 #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Blackbird PLC CEO Ian McDonough joins Proactive's Stephen Gunnion with insights into the company's 2023 performance and upcoming milestones.

McDonough described 2023 as a year of progress, highlighting Blackbird's significant presence in major sporting events due to its unparalleled speed and stability as a video editor. The company's technology was employed across numerous high-profile sports events, including all Tennis Grand Slams, the Super Bowl, the Women's World Cup, the Ryder Cup, and the Rugby World Cup, with plans to extend its use to the Summer Games in 2024.

The discussion also introduced elevate.io , a new product aimed at the creator economy, which is a level below the professional sphere where Blackbird operates. Designed with input from 300 potential users, elevate.io targets independent filmmakers, podcasters, corporate video creators, and others within a market valued at approximately $250 billion, according to Goldman Sachs, expected to grow to $500 billion by 2027. The specific segment for tools and services is anticipated to expand from $20 billion to $180 billion by 2030.

To support elevate.io 's growth, Blackbird has welcomed a new director, Anne de Kerckhove, and raised over a million pounds. The product, due for general release at the end of March, will start as a freemium model and aims to build a user community through its multiplayer and collaborative features, leveraging AWS for scalability.

For 2024, McDonough foresees a pivotal period of learning from the market and community feedback to refine and expand elevate.io's offerings, with a focus on agile development based on user needs.

#BlackbirdPLC #IanMcDonough #VideoEditing #ElevateIO #CreatorEconomy #SportingEvents #TechInnovation #SoftwareLaunch #MarketGrowth #AgileDevelopment #proactiveinvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

The FTSE 100 enjoyed a positive start as investors braced for the Chancellor’s Spring Budget later today.

A national insurance cut is widely expected to be among Jeremy Hunt’s measures in the budget, which will most likely be his last before the next general election.

Among companies, Legal & General dropped early on after reporting flat operating profit of £1.67 billion for the year, below market expectations.

Also reporting was packing firm DS Smith, which revealed flat like-for-like volumes since November but remained quiet on a potential merger with Mondi.

William Hill owner 888 Holdings climbed meanwhile, on news its lower-margin US business could be sold as part of a strategic review.

And finally, Bitcoin saw another surge this morning after briefly hitting and then declining from a $69,000 all-time high on Tuesday.

#proactiveinvestors #marketreport #ftse #footsie #ftse100 #legal&general #dssmith #springbudget #williamhill #888holdings #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Following a recent uranium acquisition, Orpheus Uranium Ltd (ASX:ORP) non-executive director Simon Mitchell joins Jonathan Jackson in the Proactive studio to share insights into the company's latest strategic moves and future direction. Mitchell provides an overview of Orpheus Uranium, detailing its key projects and objectives aimed at advancing its position in the uranium sector. He explains the company's decision to rebrand, a strategic move aimed at better reflecting its evolving focus and ambitions within the uranium industry and discusses the acquisition of the Woolshed Project, highlighting the project's potential and what made it an attractive addition to Orpheus Uranium's portfolio. The acquisition underscores the company's commitment to expanding its uranium project footprint, particularly in South Australia. Finally, Mitchell offers his perspective on the current state of the uranium market and the implications for Orpheus Uranium's strategy and operations.

#ProactiveInvestors #OrpheusUranium #ASX #Energy #uranium

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Mako Gold Ltd (ASX:MKG) managing director Peter Ledwidge joins Jonathan Jackson in the studio to talk through an extension of Tchaga North prospect at the Napié Gold Project in Côte d’Ivoire. High-grade rock chip samples from the new Double Zone at Tchaga North indicates a target with 250 metres of strike length.The new Double Zone sits on the western greenstone-granite contact at Napié, an area Mako considers to be a high-priority drill target. Ledwidge will join the company’s general manager of exploration this week to spend five weeks on-site, for on-the-ground evaluation of the new high-grade targets and for due diligence on the potential Goldridge transaction. He will also meet with the Ministry of Mines to talk about the reapplication process for Napie, which is on track and expected to be granted shortly.

#ProactiveInvestors #MakoGold #ASX #Gold #NapieGoldProject

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Graphene Manufacturing Group Ltd (CVE:GMG) CEO Craig Nicol sits down with Proactive’s Jonathan Jackson to provide insight into the energy savings and storage company and its recent achievements, including its recent listing on the OTX QX, marking a pivotal step in GMG's growth strategy. Nicol dives into the background of GMG, elaborating on its products, the importance of GMG passing an ISO audit and its commitment to maintaining high-quality standards in its operations and product development. A recent breakthrough in the development of Graphene Aluminium-Ion Battery technology was also discussed, noting its minimal temperature rise as a key advantage. Finally, Nicol touches on the establishment of a graphene production plant to scale up production and meet the growing demand for graphene-based products.

#ProactiveInvestors #GrapheneManufacturingGroup #CVE #Graphene #Graphite #BatteryMetals

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Medicus Pharma Chief Operating Officer Erica Monaco joined Steve Darling from Proactive to discuss her exciting new role within the company. Monaco brings with her a wealth of experience and a proven track record as a leader in the pharmaceutical industry, particularly within the dermatology sector.

With over a decade of experience in dermatology, Monaco has demonstrated her exceptional leadership skills by successfully building start-up operations, driving change, and implementing process improvements. Her tenure as the CEO of Biofrontera Inc exemplifies her ability to navigate complex challenges and drive sustainable growth.

During her time at Biofrontera Inc, Monaco led a pre-commercial organization through significant milestones, from FDA approval to market introduction and commercial launch. Under her leadership, the company achieved remarkable revenue growth at a compound annual growth rate (CAGR) exceeding 80%, a testament to her strategic vision and operational expertise.

Moreover, Monaco's tenure at Biofrontera Inc was marked by the completion of an accretive M&A transaction, further highlighting her ability to drive value creation and capitalize on strategic opportunities.

With her proven track record of success and extensive experience in the pharmaceutical industry, Monaco's appointment as Chief Operating Officer at Medicus Pharma underscores the company's commitment to driving innovation and growth. Her leadership will undoubtedly play a pivotal role in advancing the company's strategic objectives and achieving operational excellence.

As Monaco embarks on this new chapter with Medicus Pharma, stakeholders can expect to see continued momentum and strategic initiatives aimed at driving long-term value creation in the pharmaceutical sector. With her leadership at the helm, Medicus Pharma is well-positioned to capitalize on emerging opportunities and deliver innovative solutions to address unmet medical needs.

#proactiveinvestors #medicuspharmaltd #tsxv #mdcx #fda #clinicaltrials

#EricaMonaco, #PharmaceuticalIndustry, #SkinCancerTreatment, #MicroneedlePatch, #ClinicalTrials, #DermatologyInnovation, #PharmaLeadership, #OperationalExcellence, #HealthcareTechnology, #COOAppointment, #CancerCareInnovation, #DrugDevelopment, #PharmaNews, #BiotechInnovation, #ClinicalDevelopment, #PharmaStrategy, #CancerTreatment, #MedicalDevices, #HealthTech, #ExecutiveLeadership, #InnovativeTherapies, #PharmaIndustryNews, #SkinHealth, #Biopharmaceuticals

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews